{"name": "Atox Bio",
 "permalink": "atox-bio",
 "crunchbase_url": "http://www.crunchbase.com/company/atox-bio",
 "homepage_url": "http://www.atoxbio.com",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": null,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "dant@atoxbio.com",
 "phone_number": "972-8-648-4111",
 "description": "",
 "created_at": "Tue Dec 20 05:33:21 UTC 2011",
 "updated_at": "Wed Feb 01 02:06:02 UTC 2012",
 "overview": "\u003Cp\u003EAtox Bio is a clinical stage biotechnology company that develops therapeutics for diseases mediated by a deregulated inflammatory response. Atox Bio focuses on novel modulators of the immune response that target key multiple and interrelated pathways of both the adaptive and innate immune response that play critical roles in infectious and inflammatory diseases as well as ischemia/reperfusion injuries.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       34],
      "assets/images/resized/0016/6992/166992v1-max-150x150.jpg"],
     [[168,
       39],
      "assets/images/resized/0016/6992/166992v1-max-250x250.jpg"],
     [[168,
       39],
      "assets/images/resized/0016/6992/166992v1-max-450x450.jpg"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "CEO",
    "person":
     {"first_name": "Dan",
      "last_name": "Teleman",
      "permalink": "dan-teleman",
      "image": null}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$3.25M",
 "funding_rounds":
  [{"round_code": "a",
    "source_url": "http://www.pehub.com/129567/atox-bio-adds-325m/",
    "source_description": "Atox Bio Adds $3.25M",
    "raised_amount": 3250000.0,
    "raised_currency_code": "USD",
    "funded_year": 2011,
    "funded_month": 12,
    "funded_day": 19,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Esperante Ventures",
         "permalink": "esperante-ventures",
         "image":
          {"available_sizes":
            [[[150,
               90],
              "assets/images/resized/0008/1082/81082v2-max-150x150.png"],
             [[178,
               107],
              "assets/images/resized/0008/1082/81082v2-max-250x250.png"],
             [[178,
               107],
              "assets/images/resized/0008/1082/81082v2-max-450x450.png"]],
           "attribution": null}},
       "person": null}]}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "3 Golda Meir St.",
    "address2": "Weizmann Science Park",
    "zip_code": "74036 ",
    "city": "Ness Ziona",
    "state_code": null,
    "country_code": "ISR",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [],
 "external_links":
  []}